Insider · CIK 0001255927

Kania Edwin M Jr

CIK 0001255927 Name as filed on the most recent filing

Filed as Kania Edwin M Jr (40)

126 transaction lines · from 40 filings · filed 2004-12-06 to 2021-11-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

35 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-11-29 P, Open-market purchase TransMedics Group, Inc.TMDX 2 lines 2,256,215, acquired Open Form 4 filing 0000899243-21-046299
2020-01-14 S, Open-market sale Moderna, Inc.MRNA 2,353,841, disposed Open Form 4 filing 0000899243-20-001179
2020-01-10 S, Open-market sale Moderna, Inc.MRNA 7,269,972, disposed Open Form 4 filing 0000899243-20-001179
2019-12-11 S, Open-market sale Moderna, Inc.MRNA 2 lines 4,445,457, disposed Open Form 4 filing 0000899243-19-028975
2019-12-10 S, Open-market sale Moderna, Inc.MRNA 1,880,840, disposed Open Form 4 filing 0000899243-19-028978
2019-12-10 S, Open-market sale Moderna, Inc.MRNA 2 lines 481,871, disposed Open Form 4 filing 0000899243-19-028975
2019-12-09 S, Open-market sale Moderna, Inc.MRNA 2 lines 3,269,607, disposed Open Form 4 filing 0000899243-19-028975
2019-05-13 P, Open-market purchase Axcella Health Inc.AXLA 10,000,000, acquired Open Form 4 filing 0001104659-19-029735
2019-05-06 P, Open-market purchase TransMedics Group, Inc.TMDX 533,328, acquired Open Form 4 filing 0000899243-19-012293
2018-05-11 P, Open-market purchase Evelo Biosciences, Inc.EVLO 4,500,000, acquired Open Form 4 filing 0000899243-18-013013
2017-05-16 S, Open-market sale Selecta Biosciences IncSELB 3,735,130, disposed Open Form 4 filing 0001012975-17-000439
2016-09-23 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 4 lines 208,856, disposed Open Form 4 filing 0001012975-16-001507
2016-09-22 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 4 lines 1,194,442, disposed Open Form 4 filing 0001012975-16-001507
2016-09-21 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 2 lines 1,210,211, disposed Open Form 4 filing 0001012975-16-001505
2016-09-20 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 2 lines 182,779, disposed Open Form 4 filing 0001012975-16-001505
2016-09-19 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 2 lines 32,107, disposed Open Form 4 filing 0001012975-16-001505
2016-09-15 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 2 lines 11,153, disposed Open Form 4 filing 0001012975-16-001503
2016-09-14 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 2 lines 183,966, disposed Open Form 4 filing 0001012975-16-001503
2016-09-07 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 3 lines 422,709, disposed Open Form 4 filing 0001012975-16-001495
2016-09-06 S, Open-market sale Eleven Biotherapeutics, Inc.EBIO 3 lines 165,615, disposed Open Form 4 filing 0001012975-16-001495
2016-07-06 P, Open-market purchase Syros Pharmaceuticals, Inc.SYRS 2 lines 5,000,000, acquired Open Form 4 filing 0001104659-16-131412
2016-05-25 S, Open-market sale Seres Therapeutics, Inc.MCRB 3 lines 27,600,000, disposed Open Form 4 filing 0001012975-16-001264
2014-12-23 S, Open-market sale Acceleron Pharma IncXLRN 2 lines 2,065,300, disposed Open Form 4 filing 0001209191-14-078009
2014-12-11 S, Open-market sale BG Medicine, Inc.BGMD 2 lines 116,274, disposed Open Form 4 filing 0001181431-14-038645
2014-12-10 S, Open-market sale BG Medicine, Inc.BGMD 2 lines 36,710, disposed Open Form 4 filing 0001181431-14-038645

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 32
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. KANIA EDWIN M JR, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001255927

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.